MedMesh.i
Corpus
Accueil
Racine
Corpus
Exploration
Accueil
Racine
Accueil

Corpus GrippeAllemagneV3 - Corpus (Accueil)

Index « MedMesh.i » - entrée « Cost-Benefit Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost of Illness < Cost-Benefit Analysis < Costs and Cost Analysis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000078 (2016) Christiaan Dolk ; Martin Eichner ; Robert Welte ; Anastassia Anastassopoulou ; Laure-Anne Van Bellinghen ; Barbara Poulsen Nautrup ; Ilse Van Vlaenderen ; Ruprecht Schmidt-Ott ; Markus Schwehm ; Maarten PostmaCost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.
000114 (2015) Robin KobbeThe ESPID/ESWI Joint Symposium - A strong vote for universal influenza vaccination in children in Europe.
000161 (2015) Oliver Damm ; Martin Eichner ; Markus Andreas Rose ; Markus Knuf ; Peter Wutzler ; Johannes Günter Liese ; Hagen Krüger ; Wolfgang GreinerPublic health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.
000233 (2012) Anna K. Lugnér ; Michiel Van Boven ; Robin De Vries ; Maarten J. Postma ; Jacco WallingaCost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
000337 (????) Theodore J D. Knight-Jones ; Ruth Hauser ; Doris Matthes ; Katharina D C. St RkEvaluation of effectiveness and efficiency of wild bird surveillance for avian influenza.
000472 (????) Samuel Aballéa ; Jeremy Chancellor ; Monique Martin ; Peter Wutzler ; Fabrice Carrat ; Roberto Gasparini ; Joao Toniolo-Neto ; Michael Drummond ; Milton WeinsteinThe cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
000497 (2006) P. Wutzler[Prophylactic influenza vaccination: what is the situation in Germany?].
000517 (2001) H. Bertz[Prevention of pneumococcal infection by vaccination].
000544 (2003) R. Rychlik ; T. Heinen-Kammerer ; H. Rusche ; J. Piercy ; P. Scuffham ; Y. Zöllner[Cost-effectiveness of prophylaxis and treatment of influenza].
000560 (2002) P. Rieckmann ; K V Toyka[Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002].
000568 (2001) T. Szucs ; M. Behrens ; T. Volmer[Public health costs of influenza in Germany 1996- a cost-of-illness analysis].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Cost-Benefit Analysis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Cost-Benefit Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeAllemagneV3
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Cost-Benefit Analysis
}}
Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020